| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Melting point | 246.0 to 250.0 °C |
| Specific rotation | +20.0 ～ +24.0 deg(C=1, CHCl3) |
| Solubility | Soluble in Chloroform, Methanol, Ethanol, Acetone |
Dutasteride
(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-[2,5-Bis(trifluoromethyl)phenyl]-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide; (5α,17β)-N-[2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4-azaandrost-1-ene-17-carboxamide
| Purity / Analysis Method | >98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C27H30F6N2O2 = 528.54 |
| Physical State (20 deg.C) | Solid |
| CAS RN | 164656-23-9 |
| Unit | Price |
| 500 mg | 7000 |
| 1 g | 9975 |
| 5 g | 17500 |
| Note | • Pharmaceutical Ingredients (for Research and Experimental Use) is provided as delivered and specified by the issuing Pharmacopoeia. |
|---|
